Welcome - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Search Results Your Search for 'European Markets for Coronary Artery Bypass Graft Devices' returned 6 results - Page 1 of 1   Sort by    Date Published ASC Date Published DESC Report Price ASC Report Price DESC Rank ASC Rank DESC   Sorted by Rank Top-Bottom Drug Eluting Stents Market - Current Situation & Future Forecast   Medtech Reports, Feb 2009, Pages: 50 an understanding of this highly dynamic market. 1. Executive Summary 2. Current Market Environment 2.1 Coronary Artery Disease (CAD) 2.2 Coronary Artery Bypass & Graft (CABG) 2.3 Percutaneous Coronary Coronary Stents - Global Strategic Business Report   Global Industry Analysts, Inc., Oct 2011, Pages: 396 Table 47: European Recent Past, Current & Future Analysis for Coronary Stents by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed Drug Eluting Stents – Technology & Market Forecast   Medtech Reports, Feb 2008, Pages: 30 Disease (CAD) 2.1.1 Epidemiology 2.1.2 Diagnosis 2.1.3 Management 2.2 Medical Management 2.3 Coronary Artery Bypass & Graft (CABG) 2.4 Percutaneous Transluminal Coronary Angioplasty (PTCA) 2 Drug-Eluting Stents - Global Strategic Business Report   Global Industry Analysts, Inc., Jan 2011, Pages: 289 ) Coronary Heart Disease Traditional Methods of Treating Blockage of Coronary Arteries Percutaneous Transluminal Coronary Angioplasty (PTCA) Coronary Artery Bypass Graft (CABG) Restenosis Evolution Cell Therapy - Technologies, Markets and Companies   Jain PharmaBiotech, Feb 2012, Pages: 1008 with cells Engineered arteries for bypass grafts Fetal cardiomyocytes seeding in tissue-engineered cardiac grafts Targeted delivery of endothelial progenitor cells labeled with nanoparticles UCB progenitor Global Cardiovascular Device Markets 2007-2012   Informa Healthcare, Jan 2007, Pages: 282 .4.1 Cardiac markers 78 4.4.2 Intravascular ultrasound 79 4.4.3 Magnetic resonance imaging 80 4.4.4 Computed tomography imaging 82 4.4.5 Catheters 84 4.5 Surgery 85 4.5.1 Coronary artery bypass graft surgery 85 Results:  First -   Prev -   1 -   Next -   Last

		For enquiries please call us on:   +353-1-415-1241 (GMT Office Hours)   1-800-526-8630 (US/Canada Toll Free)   1-917-300-0470 (EST Office Hours)

All rights reserved. © Copyright 2012 Research and Markets1    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network